Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of September 2026
Chanel Holden @Chanel Holden
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,549,402talents

Virtual portfolio value:

$5,421,679talents

Net overall return per annum:

18.96%

AYA current rank order:

#8

Asset investment philosophy:
Chanel Holden trades U.S. stocks with the top #1 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 40,963 +2,108.33% $310,909
UBXG U-BX Technology Ltd. Class A Ordinary Shares $0.34 $3.98 36,511 +1,070.59% $132,900
UMAC Unusual Machines Inc. Common Stock $1.87 $18.73 6,638 +901.60% $111,917
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 75,600 +793.33% $89,964
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 2,096 +589.24% $86,083
VATE INNOVATE Corp. Common Stock $0.53 $4.14 21,396 +681.13% $77,240
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 593 +601.88% $66,351
NTZ Natuzzi S.p.A. $2.21 $11.92 6,612 +439.37% $64,203
CDNS Cadence Design Systems Inc. Common Stock $29.82 $150.85 490 +405.87% $59,305
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,122 +660.87% $48,382
Sum $1,047,254

Top 10 current stock portfolio positions as of September 2026Strategy

Symbol Company Price Position Capitalization
SEI Solaris Energy Infrastructure Inc. Class A Common Stock $70.10 1,160 $81,316
PXS Pyxis Tankers Inc. Common Stock $6.61 10,989 $72,637
TCI Transcontinental Realty Investors Inc. Common Stock $43.31 1,614 $69,902
VKTX Viking Therapeutics Inc. Common Stock $36.75 1,796 $66,003
SYM Symbotic Inc. Class A Common Stock $44.04 1,484 $65,355
TMO Thermo Fisher Scientific Inc Common Stock $678.39 95 $64,447
STRL Sterling Infrastructure Inc. Common Stock $513.72 125 $64,215
PLXS Plexus Corp. Common Stock $261.61 245 $64,094
MLAB Mesa Laboratories Inc. Common Stock $137.50 460 $63,250
GNRC Generac Holdlings Inc. Common Stock $198.05 317 $62,781
Sum $674,000

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@Andy Yeh Alpha

Blog+More

Fed's new chairman Jerome Powell testifies before Congress for the first time.

Rose Prince

2018-02-27 09:35:00 Tuesday ET

Fed's new chairman Jerome Powell testifies before Congress for the first time.

Fed's new chairman Jerome Powell testifies before Congress for the first time. He vows to prevent price instability for U.S. consumers, firms, and finan

+See More

Former IMF chief economist Kenneth Rogoff advocates that artificial intelligence helps augment productivity growth in the next decade.

James Campbell

2018-04-23 07:43:00 Monday ET

Former IMF chief economist Kenneth Rogoff advocates that artificial intelligence helps augment productivity growth in the next decade.

Harvard professor and former IMF chief economist Kenneth Rogoff advocates that artificial intelligence helps augment human productivity growth in the next d

+See More

Anti-competitive corporate practices may stifle U.S. innovation.

Fiona Sydney

2020-01-15 08:31:00 Wednesday ET

Anti-competitive corporate practices may stifle U.S. innovation.

Anti-competitive corporate practices may stifle U.S. innovation. In recent decades, wage growth, economic output, and productivity tend to stagnate as U.S.

+See More

Smart firms and customers connect the continuous flow of lean production to the lean consumption of cost-effective minimum viable products.

Olivia London

2020-07-26 15:29:00 Sunday ET

Smart firms and customers connect the continuous flow of lean production to the lean consumption of cost-effective minimum viable products.

Firms and customers create value and wealth together by joining the continual flow of small batches of lean production to the lean consumption of cost-effec

+See More

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science.

James Campbell

2023-09-14 09:28:00 Thursday ET

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science.

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science. Colin Camerer, George Loewenstei

+See More

Today, tech titans continue to reshape and even disrupt global pharmaceutical investments for both better healthspan and longer lifespan.

John Fourier

2026-10-31 12:38:00 Saturday ET

Today, tech titans continue to reshape and even disrupt global pharmaceutical investments for both better healthspan and longer lifespan.

Today tech titans and billionaires continue to reshape global pharmaceutical investments for both better healthspan and longer lifespan. We discuss, desc

+See More